amikacin has been researched along with isepamicin in 52 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 14 (26.92) | 18.7374 |
| 1990's | 19 (36.54) | 18.2507 |
| 2000's | 14 (26.92) | 29.6817 |
| 2010's | 4 (7.69) | 24.3611 |
| 2020's | 1 (1.92) | 2.80 |
| Authors | Studies |
|---|---|
| Brasseur, R; Constantinou-Kokotou, V; Georgiadis, MP; Kotretsou, S; Mingeot-Leclercq, MP; Tulkens, PM | 1 |
| Chen, JH; Shen, GH; Wu, BD; Wu, KM | 1 |
| Castanheira, M; Jones, RN; Mendes, RE; Sader, HS; Toleman, MA; Walsh, TR | 1 |
| Arakawa, Y; Ike, Y; Kimura, K; Kurokawa, H; Shibata, N; Shibayama, K; Suzuki, S; Wachino, J; Yamane, K | 1 |
| Denamur, S; Mingeot-Leclercq, MP; Tulkens, PM; Van Bambeke, F | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chow, JW; Frase, H; Smith, C; Toth, M; Vakulenko, SB | 1 |
| Brown, JM; Gonoi, T; Ishikawa, J; Kogure, T; Mikami, Y; Shimada, R; Yazawa, K | 1 |
| Dinwiddie, CB; Isaacs, LL; Luft, FC; Rankin, LI; Sloan, RS; Yum, MN | 1 |
| Kabins, SA; Nathan, C | 1 |
| Blaser, J | 1 |
| Feldman, S; Ravis, WR; Van, R; Walterspiel, JN | 1 |
| Bagger-Sjöbäck, D; Harada, Y; Hirakawa, K; Nikaido, M; Nishida, I; Takumida, M | 1 |
| Hiraga, Y; Kobayashi, H; Nagahama, F; Nakabayashi, T; Nakayama, I; Onodera, S; Oshitani, H; Saito, A; Sasaki, N; Yoshida, M | 1 |
| Mizuno, A; Nakashima, M; Sato, R; Suzuki, Y; Uematsu, T; Yamazaki, T | 1 |
| Hara, H; Hara, T; Iizuka, K; Matsumoto, K; Morino, T; Motoyama, K; Sano, K; Yamamoto, H | 1 |
| Endo, H; Matsumoto, K; Miura, M; Morino, T; Sano, K; Shiraiwa, K; Yamamoto, H | 1 |
| Iizuka, K; Matsumoto, K; Miura, M; Morino, T; Nakanishi, D; Sano, K; Yamamoto, H | 1 |
| Fujii, H; Matsumoto, K; Miura, M; Morino, T; Shiraiwa, K; Yamamoto, H | 1 |
| Hokonohara, T; Mochizuki, D; Shinoda, Y; Takayanagi, N | 1 |
| Endo, S; Morishita, M; Nakanishi, D; Sakai, A; Shirai, M; Somiya, Y; Suzuki, T | 1 |
| Norden, CW; Schafer, F | 1 |
| Bendirdjian, JP; Fillastre, JP; Foucher, B | 1 |
| Badal, RE; Baker, CN; Barry, AL; Jones, RN; Packer, RR; Thornsberry, C | 1 |
| Barry, AL; Gerlach, EH; Jones, RN; Thornsberry, C | 1 |
| Chapuis, C; de Montclos, M; Flandrois, JP; Guinet, M | 1 |
| Godard, C; Hannecart-Pokorni, E; Hubrechts, JM; Maes, P; Nulens, E; Nyssen, HJ; Vanhoof, R; Wildemauwe, C | 1 |
| Carbon, C; Farinotti, R; Goldstein, F; Gutmann, L; Mainardi, JL; Mohler, J; Zhou, XY | 1 |
| Blaise, D; Cordonnier, C; Espinouse, D; Herbrecht, R; Leblond, V; Minozzi, C; Sadoun, A; Sauvage, C | 1 |
| Colardyn, F | 1 |
| Covi, M; Velluti, G | 1 |
| Sturm, W | 1 |
| Esparza-Ahumada, S; Morfin-Otero, R; Rodriguez-Noriega, E | 1 |
| Beaucaire, G | 1 |
| Bamonte, F; Dionisotti, S; Fredelius, L; Ongini, E; Wersäll, J | 1 |
| Carbon, C | 1 |
| Principi, N; Viganò, A | 1 |
| Carbon, C; Caulin, E; Collatz, E; Coutrot, A | 1 |
| Izard, D; Vachée, A; Vincent, P | 1 |
| Cumps, J; El Mouedden, M; Laurent, G; Mingeot-Leclercq, MP; Taper, HS; Tulkens, PM | 1 |
| Hosino, K; Iwai, Y; Nakamura, A; Nakamura, S; O'Hara, K; Sawai, T; Seto, I | 1 |
| Bartsokas, C; Delis, D; Kafetzis, DA; Maltezou, HC; Mavrikou, M; Paraskakis, I; Siafas, C | 1 |
| Minami, S; Ogake, N; Takahata, M; Yamashiro, Y | 1 |
| Adinolfi, LE; Andreana, A; Ragone, E; Sarnataro, G; Tripodi, MF; Utili, R | 1 |
| Chen, YS; Lee, SS; Lin, HH; Lin, WR; Liu, YC; Tsai, TH; Wann, SR; Yen, MY | 1 |
| Baka, M; Gombakis, N; Kafetzis, DA; Koliouskas, DE; Kosmidou, H; Malaka-Zafiriou, E; Maltezou, HC | 1 |
| Minami, S; Takahata, M; Yamada, H | 1 |
| Iyobe, S; Okubo, T | 1 |
| Fujita, Y; Horiuchi, R; Hosokawa, S; Nakamura, K; Yamamoto, K | 1 |
| Falagas, ME; Georgantzi, GG; Karageorgopoulos, DE; Rafailidis, PI; Sun, C; Wang, R | 1 |
| Chang, SC; Ho, MW; Hseuh, PR; Lee, CH; Liu, JW; Liu, JY; Sheng, WH; Wang, FD; Wang, JT | 1 |
| Ali, HB; Asuman, B; Kubra, HU; Sarah, AF; Sreylis, N; Yeliz, TC | 1 |
1 review(s) available for amikacin and isepamicin
| Article | Year |
|---|---|
Susceptibility of Gram-negative bacteria to isepamicin: a systematic review.
Topics: Adult; Amikacin; Anti-Bacterial Agents; Child; Child, Preschool; Databases, Bibliographic; Drug Administration Schedule; Drug Resistance, Bacterial; Gentamicins; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Infant; Microbial Sensitivity Tests | 2012 |
11 trial(s) available for amikacin and isepamicin
| Article | Year |
|---|---|
Isepamicin once daily plus ceftriaxone versus amikacin plus ceftriaxone in febrile neutropenic patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Bone Marrow Transplantation; Ceftriaxone; Drug Administration Schedule; Drug Therapy, Combination; Female; Fever; Gentamicins; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Superinfection | 1995 |
The efficacy and safety of isepamicin and ceftazidime compared with amikacin and ceftazidime in acute lower respiratory tract infection.
Topics: Acute Disease; Amikacin; Anti-Bacterial Agents; Bronchitis; Ceftazidime; Cross Infection; Drug Administration Schedule; Drug Therapy, Combination; Female; Gentamicins; Gram-Negative Bacterial Infections; Humans; Male; Middle Aged; Pneumonia, Bacterial; Respiratory Tract Infections; Retrospective Studies | 1995 |
Comparison of the efficacy and safety of isepamicin and amikacin in the treatment of acute lower respiratory tract infections caused by gram-negative organisms.
Topics: Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Bronchitis; Drug Administration Schedule; Drug Therapy, Combination; Female; Gentamicins; Gram-Negative Bacterial Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Pneumonia, Bacterial; Prospective Studies; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Tract Infections | 1995 |
Isepamicin versus amikacin in the treatment of urinary tract infection.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Escherichia coli Infections; Female; Follow-Up Studies; Gentamicins; Humans; Male; Middle Aged; Prospective Studies; Pseudomonas aeruginosa; Pseudomonas Infections; Urinary Tract Infections | 1995 |
Comparison of the efficacy and safety of isepamicin and amikacin in the treatment of skin and skin structure infections.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Drug Administration Schedule; Escherichia coli Infections; Female; Gentamicins; Gram-Negative Bacterial Infections; Humans; Male; Middle Aged; Proteus Infections; Proteus mirabilis; Pseudomonas aeruginosa; Pseudomonas Infections; Skin Diseases, Bacterial; Staphylococcal Skin Infections; Staphylococcus aureus | 1995 |
Evaluation of the efficacy and safety of isepamicin compared with amikacin in the treatment of nosocomial pneumonia and septicaemia.
Topics: Amikacin; Anti-Bacterial Agents; Bacteremia; Cross Infection; Drug Therapy, Combination; Female; Gentamicins; Gram-Negative Bacterial Infections; Humans; Lactams; Male; Middle Aged; Pneumonia, Bacterial; Prospective Studies | 1995 |
Overview of the efficacy of isepamicin in the adult core clinical trial programme.
Topics: Abdomen; Adult; Aged; Amikacin; Anti-Bacterial Agents; Bacteremia; Drug Administration Schedule; Female; Gentamicins; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Prospective Studies; Respiratory Tract Infections; Skin Diseases, Bacterial; Urinary Tract Infections | 1995 |
A randomised comparison of isepamicin and amikacin in the treatment of bacterial infections in paediatric patients.
Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Bacterial Infections; Child; Child, Preschool; Drug Administration Schedule; Enterococcus faecalis; Escherichia coli Infections; Female; Gentamicins; Humans; Infant; Infant, Newborn; Klebsiella Infections; Klebsiella pneumoniae; Male; Staphylococcal Infections; Staphylococcus epidermidis; Streptococcal Infections | 1995 |
Isepamicin versus amikacin for the treatment of acute pyelonephritis in children.
Topics: Amikacin; Anti-Bacterial Agents; Child; Child, Preschool; Escherichia coli; Escherichia coli Infections; Female; Gentamicins; Humans; Infant; Infant, Newborn; Male; Pyelonephritis; Treatment Outcome; Urine | 2000 |
Once daily isepamicin treatment in complicated urinary tract infections.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Drug Administration Schedule; Female; Gentamicins; Humans; Male; Middle Aged; Prospective Studies; Urinary Tract Infections | 1999 |
Comparison of isepamicin with amikacin for the empirical treatment of febrile neutropenic children with malignancies.
Topics: Amikacin; Anti-Bacterial Agents; Bacterial Infections; Child; Child, Preschool; Drug-Related Side Effects and Adverse Reactions; Fever; Gentamicins; Humans; Male; Neoplasms; Neutropenia; Random Allocation | 2001 |
40 other study(ies) available for amikacin and isepamicin
| Article | Year |
|---|---|
Synthesis and antimicrobial and toxicological studies of amino acid and peptide derivatives of kanamycin A and netilmicin.
Topics: Amino Acids; Animals; Anti-Bacterial Agents; Bacteria; Chemical Phenomena; Chemistry, Physical; Enzyme Inhibitors; Gentamicins; Kanamycin; Lysosomes; Molecular Conformation; Netilmicin; Peptides; Phosphatidylcholines; Phospholipases A; Phospholipases A1; Rats; Thermodynamics | 1995 |
In Vitro activities of isepamicin, other aminoglycosides, and capreomycin against clinical isolates of rapidly growing mycobacteria in Taiwan.
Topics: Aminoglycosides; Anti-Bacterial Agents; Capreomycin; Gentamicins; Humans; Microbial Sensitivity Tests; Mycobacterium chelonae; Mycobacterium fortuitum; Nontuberculous Mycobacteria | 2007 |
Characterization of an integron carrying blaIMP-1 and a new aminoglycoside resistance gene, aac(6')-31, and its dissemination among genetically unrelated clinical isolates in a Brazilian hospital.
Topics: Acinetobacter; Amino Acid Sequence; Aminoglycosides; Anti-Bacterial Agents; Base Sequence; Brazil; Codon, Terminator; Cross Infection; Drug Resistance, Multiple, Bacterial; Gene Transfer, Horizontal; Genes, Bacterial; Hospitals; Humans; Integrons; Microbial Sensitivity Tests; Molecular Sequence Data; Open Reading Frames; Plasmids; Pseudomonas putida; Transcription, Genetic | 2007 |
Novel plasmid-mediated 16S rRNA m1A1408 methyltransferase, NpmA, found in a clinically isolated Escherichia coli strain resistant to structurally diverse aminoglycosides.
Topics: Amino Acid Sequence; Aminoglycosides; Anti-Bacterial Agents; Chromatography, High Pressure Liquid; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Proteins; Methyltransferases; Microbial Sensitivity Tests; Models, Molecular; Molecular Sequence Data; Plasmids; Protein Binding; Ribosome Subunits, Small; RNA, Ribosomal, 16S; Sequence Homology, Amino Acid | 2007 |
Apoptosis induced by aminoglycosides in LLC-PK1 Cells: comparative study of neomycin, gentamicin, amikacin, and isepamicin using electroporation.
Topics: Amikacin; Aminoglycosides; Animals; Anti-Bacterial Agents; Apoptosis; Electroporation; Gentamicins; LLC-PK1 Cells; Neomycin; Swine | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Mutant APH(2'')-IIa enzymes with increased activity against amikacin and isepamicin.
Topics: Aged; Amikacin; Amino Acid Substitution; Anti-Bacterial Agents; Bacterial Proteins; Base Sequence; Directed Molecular Evolution; DNA Primers; DNA, Bacterial; Drug Resistance, Bacterial; Escherichia coli; Gentamicins; Humans; Kinetics; Models, Molecular; Molecular Sequence Data; Mutagenesis; Mutation; Phosphotransferases (Alcohol Group Acceptor); Protein Structure, Tertiary; Recombinant Proteins; Sequence Homology, Amino Acid | 2010 |
Homozygous triplicate mutations in three 16S rRNA genes responsible for high-level aminoglycoside resistance in Nocardia farcinica clinical isolates from a Canada-wide bovine mastitis epizootic.
Topics: Amikacin; Aminoglycosides; Animals; Anti-Bacterial Agents; Base Sequence; Canada; Cattle; DNA Primers; Drug Resistance, Bacterial; Female; Genes, Bacterial; Homozygote; In Vitro Techniques; Mastitis, Bovine; Microbial Sensitivity Tests; Nocardia; Nocardia Infections; Point Mutation; RNA, Bacterial; RNA, Ribosomal, 16S | 2010 |
Comparative nephrotoxicity of SCH 21420 and amikacin in rats.
Topics: Amikacin; Animals; Creatinine; Enzymes; Gentamicins; Kanamycin; Kidney Diseases; Male; Proteinuria; Rats; Time Factors | 1979 |
In vitro activity of Sch 21420, derivative of gentamicin B, compared to that of amikacin.
Topics: Acetyltransferases; Amikacin; Aminoglycosides; Bacteria; Drug Resistance, Microbial; Gentamicins; Kanamycin; Microbial Sensitivity Tests | 1978 |
Efficacy of once- and thrice-daily dosing of aminoglycosides in in-vitro models of infection.
Topics: Amikacin; Anti-Bacterial Agents; Drug Administration Schedule; Fluorescence Polarization Immunoassay; Gentamicins; Netilmicin; Pseudomonas aeruginosa; Serratia marcescens | 1991 |
Comparative inactivation of isepamicin, amikacin, and gentamicin by nine beta-lactams and two beta-lactamase inhibitors, cilastatin and heparin.
Topics: Amikacin; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactams; Cilastatin; Drug Interactions; Fluorescence Polarization Immunoassay; Gentamicins; Heparin; Humans | 1991 |
Effect of dosing schedule on aminoglycoside ototoxicity: comparative cochlear ototoxicity of amikacin and isepamicin.
Topics: Amikacin; Animals; Cochlea; Drug Administration Schedule; Gentamicins; Guinea Pigs; Hair Cells, Auditory; Hair Cells, Auditory, Inner; Injections, Intramuscular; Organ of Corti; Vestibule, Labyrinth | 1990 |
[Comparison of HAPA-B and amikacin in the treatment of respiratory tract infections].
Topics: Adult; Aged; Aged, 80 and over; Amikacin; Gentamicins; Humans; Middle Aged; Respiratory Tract Infections | 1986 |
Evaluation of a fluorescence polarization immunoassay procedure for quantitation of isepamicin, a new aminoglycoside antibiotic.
Topics: Adult; Amikacin; Bilirubin; Biological Assay; Chromatography, High Pressure Liquid; Drug Interactions; Gentamicins; Hemolysis; Humans; Immunoassay; Male; Reproducibility of Results; Tobramycin | 1988 |
[Toxicological studies on isepamicin (HAPA-B). I. Acute toxicity test in the mouse, rat and dog].
Topics: Administration, Oral; Amikacin; Animals; Dogs; Female; Gentamicins; Injections, Intramuscular; Injections, Intravenous; Lethal Dose 50; Male; Mice; Rats | 1986 |
[Toxicological studies on isepamicin (HAPA-B). II. Intramuscular subacute toxicity test in the rat].
Topics: Amikacin; Animals; Body Weight; Dose-Response Relationship, Drug; Female; Gentamicins; Injections, Intramuscular; Kidney; Male; Rats | 1986 |
[Toxicological studies on isepamicin (HAPA-B). IV. Intramuscular subacute toxicity test in the dog].
Topics: Amikacin; Animals; Dogs; Dose-Response Relationship, Drug; Female; Gentamicins; Injections, Intramuscular; Kidney; Male; Organ Size | 1986 |
[Toxicological studies on isepamicin (HAPA-B). VII. Chronic intramuscular test in the rat].
Topics: Amikacin; Animals; Blood Chemical Analysis; Dose-Response Relationship, Drug; Female; Gentamicins; Injections, Intramuscular; Kidney; Male; Organ Size; Rats | 1986 |
[The neuromuscular blocking activity of isepamicin sulfate (HAPA-B) compared with other aminoglycoside antibiotics].
Topics: Amikacin; Aminoglycosides; Animals; Dose-Response Relationship, Drug; Gentamicins; In Vitro Techniques; Infusions, Intravenous; Male; Neuromuscular Blocking Agents; Rats; Rats, Inbred Strains | 1987 |
[Studies on the metabolic fate of isepamicin sulfate (HAPA-B). V. Plasma concentrations of HAPA-B in dogs after multiple administrations].
Topics: Amikacin; Aminoglycosides; Animals; Dogs; Female; Gentamicins; Injections, Intramuscular; Kinetics; Male; Models, Biological | 1987 |
Activity of amikacin, gentamicin and Schering 21420 when combined with carbenicillin or piperacillin against Pseudomonas aeruginosa.
Topics: Amikacin; Aminoglycosides; Carbenicillin; Drug Synergism; Gentamicins; Penicillins; Piperacillin; Pseudomonas aeruginosa | 1982 |
Comparative study of the effects of sagamicin, 1 N-HABA-sagamicin, UK-4, Sch 21420, gentamicin and amikacin on the respiration activity of isolated rat kidney mitochondria.
Topics: Amikacin; Aminoglycosides; Animals; Anti-Bacterial Agents; Gentamicins; In Vitro Techniques; Kanamycin; Kidney; Mitochondria; Oxygen Consumption; Rats; Structure-Activity Relationship | 1980 |
Comparison of in vitro activity of Sch 21420, a gentamicin B derivative, with those of amikacin, gentamicin, netilmicin, sisomicin, and tobramycin.
Topics: Amikacin; Anti-Bacterial Agents; Bacteria; Drug Resistance, Microbial; Gentamicins; Microbial Sensitivity Tests; Netilmicin; Sisomicin; Tobramycin | 1980 |
Interpretive standards for disk susceptibility tests with Sch 21420 and amikacin.
Topics: Amikacin; Bacteria; Gentamicins; Kanamycin; Microbial Sensitivity Tests; Regression Analysis | 1980 |
[Post-antibiotic effect of three aminoglycosides against Klebsiella pneumoniae].
Topics: Amikacin; Dose-Response Relationship, Drug; Filtration; Gentamicins; In Vitro Techniques; Klebsiella pneumoniae; Netilmicin | 1994 |
Serotypes and extended spectrum beta-lactam resistance in aminoglycoside resistant Pseudomonas aeruginosa isolates from two Belgian general hospitals: a seven year study.
Topics: Amikacin; Anti-Bacterial Agents; Belgium; beta-Lactams; Cross Infection; Drug Resistance, Microbial; Gentamicins; Hospitals; Humans; Pseudomonas aeruginosa; Serotyping | 1993 |
Activity of isepamicin and selection of permeability mutants to beta-lactams during aminoglycoside therapy of experimental endocarditis due to Klebsiella pneumoniae CF104 producing an aminoglycoside acetyltransferase 6' modifying enzyme and a TEM-3 beta-l
Topics: Acetyltransferases; Amikacin; Animals; Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; beta-Lactamases; beta-Lactams; Cell Membrane Permeability; Disease Models, Animal; Drug Therapy, Combination; Endocarditis; Female; Gentamicins; Klebsiella pneumoniae; Mutation; Rabbits | 1994 |
Auditory impairment in guinea pigs treated with isepamicin.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Auditory Threshold; Body Weight; Brain; Cochlear Duct; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Evoked Potentials, Auditory, Brain Stem; Gentamicins; Guinea Pigs; Hair Cells, Auditory; Hearing Disorders; Male; Microscopy, Electron, Scanning | 1995 |
Resistance to amikacin and isepamicin in rabbits with experimental endocarditis of an aac(6')-Ib-bearing strain of Klebsiella pneumoniae susceptible in vitro.
Topics: Acetyltransferases; Amikacin; Animals; Anti-Bacterial Agents; Colony Count, Microbial; Drug Resistance, Microbial; Endocarditis; Female; Genes, Bacterial; Gentamicins; Klebsiella Infections; Klebsiella pneumoniae; Male; Mice; Rabbits | 1996 |
[Sensitivity of Pseudomonas aeruginosa to amikacin and to isepamicin in surgery and in intensive care].
Topics: Amikacin; Anti-Bacterial Agents; Cross Infection; Drug Resistance, Microbial; Gentamicins; Humans; Intensive Care Units; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Surgery Department, Hospital | 1997 |
Apoptosis in renal proximal tubules of rats treated with low doses of aminoglycosides.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Apoptosis; Blood Urea Nitrogen; Cell Division; Creatinine; Female; Gentamicins; In Situ Nick-End Labeling; Kidney Cortex; Kidney Tubules, Proximal; Netilmicin; Phospholipids; Rats; Rats, Wistar | 2000 |
[The resistance of recent clinical isolates against isepamycin, other aminoglycosides and injectable beta-lactams].
Topics: Amikacin; Anti-Bacterial Agents; Bacteria; Ceftazidime; Dibekacin; Drug Resistance, Microbial; Gentamicins; Humans; Imipenem; Piperacillin; Tobramycin | 2000 |
[In vitro interaction of piperacillin and imipenem/cilastatin combined with aminoglycosides against Pseudomonas aeruginosa].
Topics: Amikacin; Anti-Bacterial Agents; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Gentamicins; Imipenem; Netilmicin; Penicillins; Piperacillin; Pseudomonas aeruginosa; Tobramycin | 2000 |
Comparative activities of isepamicin, amikacin, cefepime, and ciprofloxacin alone or in combination with other antibiotics against Stenotrophomonas maltophilia.
Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Cefepime; Cephalosporins; Ciprofloxacin; Colony Count, Microbial; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Drug Synergism; Drug Therapy, Combination; Gentamicins; Gram-Negative Bacterial Infections; Microbial Sensitivity Tests; Stenotrophomonas maltophilia; Time Factors | 2001 |
[In vitro interaction of tazobactam/piperacillin combined with aminoglycosides against Pseudomonas aeruginosa, Klebsiella pneumoniae, Escherichia coli AND Staphylococcus aureus].
Topics: Amikacin; Anti-Bacterial Agents; Drug Antagonism; Drug Combinations; Drug Resistance, Bacterial; Drug Synergism; Enzyme Inhibitors; Escherichia coli; Gentamicins; Microbial Sensitivity Tests; Penicillanic Acid; Penicillins; Piperacillin; Pseudomonas aeruginosa; Staphylococcus aureus; Tazobactam | 2002 |
[Antibacterial activities and PK/PD parameters of aminoglycosides against recent clinical isolates of gram-negative rods].
Topics: Amikacin; Anti-Bacterial Agents; Dibekacin; Drug Resistance, Microbial; Gentamicins; Gram-Negative Bacteria; Humans; Netilmicin; Tobramycin | 2002 |
Determination of isepamicin in human plasma by HPLC with fluorescence detection after derivatization using 6-aminoquinolyl-N-hydroxysuccinimidyl-carbamate.
Topics: Amikacin; Aminoquinolines; Anti-Bacterial Agents; Carbamates; Carbohydrate Sequence; Chromatography, High Pressure Liquid; Gentamicins; Humans; Indicators and Reagents; Molecular Sequence Data; Reproducibility of Results; Spectrometry, Fluorescence | 2008 |
In vitro activity of aminoglycosides against clinical isolates of Acinetobacter baumannii complex and other nonfermentative Gram-negative bacilli causing healthcare-associated bloodstream infections in Taiwan.
Topics: Acinetobacter baumannii; Amikacin; Aminoglycosides; Anti-Bacterial Agents; Bacteremia; Burkholderia cepacia; Cross Infection; Drug Resistance, Bacterial; Gentamicins; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Stenotrophomonas maltophilia; Tobramycin | 2016 |
Investigation of isepamicin in vitro efficiency in Gram negative bacteria efficacy of isepamicin.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Carbapenems; Gentamicins; Gram-Negative Bacteria; Microbial Sensitivity Tests; Netilmicin; Pseudomonas aeruginosa; Tobramycin | 2021 |